Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucosidase, alpha | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0815 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0.0815 | 0.5 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0.0815 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1807 | 0.1807 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1807 | 0.1807 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0664 | 0.0664 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0815 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2521 | 0.1872 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0044 | 0.0815 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.8356 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.0975 | 0.0333 |
Trypanosoma brucei | glucosidase, putative | 0.0044 | 0.0815 | 0.5 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0044 | 0.0815 | 0.0161 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0.0815 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1807 | 0.1224 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0044 | 0.0815 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0815 | 0.5 |
Onchocerca volvulus | 0.0114 | 0.5023 | 0.5 | |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0044 | 0.0815 | 0.0815 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0044 | 0.0815 | 0.5 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0044 | 0.0815 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 1 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0044 | 0.0815 | 0.5 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0044 | 0.0815 | 0.0017 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0197 | 1 | 1 |
Schistosoma mansoni | alpha glucosidase | 0.0044 | 0.0815 | 0.0195 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0044 | 0.0815 | 0.5 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0197 | 1 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.3629 | 0.3629 |
Schistosoma mansoni | alpha-glucosidase | 0.0169 | 0.8356 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.1147 | 0.0517 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0197 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.1285 | 0.0665 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.097 | 0.097 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0815 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.278 | 0.2751 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.2521 | 0.1872 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0044 | 0.0815 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0044 | 0.0815 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.3319 | 0.2844 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0044 | 0.0815 | 0.0017 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1807 | 0.1224 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | = 7.0795 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 14.7157 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 28.1838 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.